Bausch Health Companies Inc
BHC
Market Cap$2.74B
Close$
$20.16
174.3% upside
Current Fair Value
174.3% upsideUndervalued by 174.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.74 Billion |
|---|---|
| Enterprise Value | $2.52 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.13 |
| Beta | 0.41 |
| Outstanding Shares | 370,900,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 28.08 |
|---|---|
| PEG | 53.41 |
| Price to Sales | 0.28 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.26 |
| Enterprise Value to EBIT | 1.58 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | -1.97 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bausch Health Companies Inc
21,100 employeesBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...